Technologies & Start-ups
Uniseed Portfolio (Melbourne-based)
For further information on the following projects, please contact the Uniseed Investment Committee Project Manager or the Uniseed Regional Director.
Hatchtech Pty Ltd
Low Toxicity Insecticides. Hatchtech is a start-up company that builds on the expertise of staff at the University of Melbourne's Centre for Animal Biotechnology to develop a new generation of low-toxicity ovacides for human parasites.
Radical Biotechnology Pty Ltd
Novel Cardiovascular Disease Therapy. Radical Biotechnology aims to develop the first class of therapeutics that actually target the underlying cause of cardiovascular disease, rather than the symptoms, thus inhibiting and possibly reversing its progression.
Velacor Therapeutics Pty Limited
A novel approach to cancer treatment. Velacor is developing a novel treatment for prostate cancer through inhibition of the protein kinase Akt pathway.
To discuss any of these UniSeed investments, please contact:
John Kurek
Melbourne Investment Manager
Uniseed
211 Grattan Street
Carlton Victoria. 303
Australia
Email: j.kurek@uniseed.com
Phone: +61 3 8344 3193
Fax: +61 3 9347 5888
Peter Devine
Chief Executive Officer
Uniseed Management Pty Ltd
Level 7, GP South Building
Staff House Road
St. Lucia QLD 407
Email: p.devine@uniseed com
Phone: +61 7 3365 6937
Fax: +61 7 3365 4433
Other Businesses
NeuProtect
NeuProtect is a drug development company, spun-off from The University of Melbourne and the Howard Florey Institute of Experimental Physiology & Medicine.
TeeleOstin
TeeleOstin is a drug development company, spun-off from The University of Melbourne and St Vincents Institute of Medical Research, focused on the development of a therapy for osteoporosis based on fish parathyroid hormone.